116 related articles for article (PubMed ID: 3292601)
1. Superactivated charcoal versus cholestyramine for cholesterol lowering: a randomized cross-over trial.
Park GD; Spector R; Kitt TM
J Clin Pharmacol; 1988 May; 28(5):416-9. PubMed ID: 3292601
[TBL] [Abstract][Full Text] [Related]
2. Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine.
Neuvonen PJ; Kuusisto P; Vapaatalo H; Manninen V
Eur J Clin Pharmacol; 1989; 37(3):225-30. PubMed ID: 2612535
[TBL] [Abstract][Full Text] [Related]
3. SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.
Benson GM; Alston DR; Bond BC; Gee AN; Glen A; Haynes C; Hickey DM; Iqbal S; Jackson B; Jaxa-Chamiec AA
Atherosclerosis; 1993 Jun; 101(1):51-60. PubMed ID: 8216502
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
5. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
Watermeyer GS; Mann JI; Truswell AS; Levy I
S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
[TBL] [Abstract][Full Text] [Related]
6. Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
Sprecher DL; Abrams J; Allen JW; Keane WF; Chrysant SG; Ginsberg H; Fischer JJ; Johnson BF; Theroux P; Jokubaitis L
Ann Intern Med; 1994 Apr; 120(7):537-43. PubMed ID: 8093139
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
8. The effect of cholestyramine and activated charcoal on glipizide absorption.
Kivistö KT; Neuvonen PJ
Br J Clin Pharmacol; 1990 Nov; 30(5):733-6. PubMed ID: 2271372
[TBL] [Abstract][Full Text] [Related]
9. Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramine.
Ferry DG; Gazeley LR; Busby WJ; Beasley DM; Edwards IR; Campbell AJ
Eur J Clin Pharmacol; 1990; 39(6):599-601. PubMed ID: 2095346
[TBL] [Abstract][Full Text] [Related]
10. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
Angelin B; Einarsson K
Atherosclerosis; 1981; 38(1-2):33-8. PubMed ID: 7470203
[TBL] [Abstract][Full Text] [Related]
11. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
Ditschuneit HH; Dreyer M; Dammann HG; Ditschuneit H
Med Klin (Munich); 1991 Mar; 86(3):142-8. PubMed ID: 1903497
[TBL] [Abstract][Full Text] [Related]
12. Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.
Deslypere JP
Acta Cardiol; 1989; 44(5):379-88. PubMed ID: 2690545
[TBL] [Abstract][Full Text] [Related]
13. Hypocholesterolemic agents: a comparison of the relative effectiveness of cholestyramine and pectin in rats.
Baig MM; Burgin CW; Cerda JJ
Drug Nutr Interact; 1985; 3(2):109-13. PubMed ID: 3987520
[TBL] [Abstract][Full Text] [Related]
14. Correlative studies of the hypocholesterolemic effect of a highly activated charcoal.
Tishler PV; Winston SH; Bell SM
Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):799-806. PubMed ID: 3441164
[TBL] [Abstract][Full Text] [Related]
15. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
[TBL] [Abstract][Full Text] [Related]
16. Effect of bran and cholestyramine on plasma lipids in monkeys.
Malinow MR; McLaughlin P; Papworth L; Naito HK; Lewis LA
Am J Clin Nutr; 1976 Aug; 29(8):905-11. PubMed ID: 821335
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.
Pan HY; DeVault AR; Swites BJ; Whigan D; Ivashkiv E; Willard DA; Brescia D
Clin Pharmacol Ther; 1990 Aug; 48(2):201-7. PubMed ID: 2116260
[TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
Rabelink AJ; Hené RJ; Erkelens DW; Joles JA; Koomans HA
Lancet; 1988 Dec; 2(8624):1335-8. PubMed ID: 2904053
[TBL] [Abstract][Full Text] [Related]
19. Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
Hagen E; Istad H; Ose L; Bodd E; Eriksen HM; Selvig V; Bard JM; Fruchart JC; Borge M; Wolf MC
Eur J Clin Pharmacol; 1994; 46(5):445-9. PubMed ID: 7957541
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
